Evidence map›Paper›PMID 37378812›Full record

ReviewJournal of cell communication and signaling2023

The advance of CCN3 in fibrosis.

Hui Yin, Na Liu, Xianming Zhou, Jie Chen, Lihua Duan

Open access · greenAbstract readReview
In one paragraph

Review in Journal of cell communication and signaling, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Review
  6. Article
  7. Review
  8. [Research advances of collagen-based biomaterials in wound repair].Zhonghua shao shang yu chuang mian xiu fu za zhi · 2024
    Review
  9. Review
  10. Review
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Hui YinDepartment of Rheumatology and Clinical Immunology, Jiangxi Provincial People's Hospital, Nanchang, 330006, China.
Na LiuDepartment of Rheumatology and Clinical Immunology, Jiangxi Provincial People's Hospital, Nanchang, 330006, China.
Xianming ZhouDepartment of Cardiovascular Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Jie ChenDepartment of Rheumatology and Clinical Immunology, Jiangxi Provincial People's Hospital, Nanchang, 330006, China.
Lihua DuanDepartment of Rheumatology and Clinical Immunology, Jiangxi Provincial People's Hospital, Nanchang, 330006, China. lh-duan@163.com.
Jiangxi Provincial People's Hospital · CNFirst Affiliated Hospital of Jiangxi Medical College · CNHuazhong University of Science and Technology · CN

Funding

National Natural Science Foundation of China 81960296Natural Science Foundation of Jiangxi Province 20202ACBL206011
6 · The paper itself

Abstract

The extracellular matrix (ECM) is comprised of various extracellular macromolecules, including collagen, enzymes, and glycoproteins, which offer structural and biochemical support to neighboring cells. After tissue injury, extracellular matrix proteins deposit in the damaged tissue to promote tissue healing. However, an imbalance between ECM production and degradation can result in excessive deposition, leading to fibrosis and subsequent organ dysfunction. Acting as a regulatory protein within the extracellular matrix, CCN3 plays a crucial role in numerous biological processes, such as cell proliferation, angiogenesis, tumorigenesis, and wound healing. Many studies have demonstrated that CCN3 can reduce the production of ECM in tissues through diverse mechanisms thereby exerting an inhibitory effect on fibrosis. Consequently, CCN3 emerges as a promising therapeutic target for ameliorating fibrosis.

Indexed as

CCN2CCN3CCN familyExtracellular matrixFibrosis

Identifiers

PMID37378812
PMCPMC10713972
OpenAlexW4382345211

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.